Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ricardo Lima Barros Costa"'
Autor:
Massimo Cristofanilli, William J. Gradishar, Leonidas C. Platanias, Firas H. Wehbe, Amir Behdad, Timothy J. Taxter, Vittorina Zagonel, Rebecca J. Nagy, Ricardo Lima Barros Costa, Kimberly S. Strickland, Laura K. Austin, Alfred W. Rademaker, Zhaomei Mu, Giovanna Rossi
Distribution of the patients according to the change of treatment based on ctDNA findings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a24f9588c4fd4a62cd89d3339d22ee15
https://doi.org/10.1158/1078-0432.22465212.v1
https://doi.org/10.1158/1078-0432.22465212.v1
Autor:
Massimo Cristofanilli, William J. Gradishar, Leonidas C. Platanias, Firas H. Wehbe, Amir Behdad, Timothy J. Taxter, Vittorina Zagonel, Rebecca J. Nagy, Ricardo Lima Barros Costa, Kimberly S. Strickland, Laura K. Austin, Alfred W. Rademaker, Zhaomei Mu, Giovanna Rossi
Distribution of the previous treatments (before the ESR1 mutation detection) in the subgroup of patients with ER+ ESR1+ disease versus the patients with ER+ ESR1- disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5cad05d82f303561b0c92c64bdcfb1a
https://doi.org/10.1158/1078-0432.22465215.v1
https://doi.org/10.1158/1078-0432.22465215.v1
Autor:
Massimo Cristofanilli, William J. Gradishar, Leonidas C. Platanias, Firas H. Wehbe, Amir Behdad, Timothy J. Taxter, Vittorina Zagonel, Rebecca J. Nagy, Ricardo Lima Barros Costa, Kimberly S. Strickland, Laura K. Austin, Alfred W. Rademaker, Zhaomei Mu, Giovanna Rossi
Guardant360TM: 70-Gene Panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3354173c9c71bbea7465a4baa5326c26
https://doi.org/10.1158/1078-0432.22465218
https://doi.org/10.1158/1078-0432.22465218
Autor:
Massimo Cristofanilli, William J. Gradishar, Leonidas C. Platanias, Firas H. Wehbe, Amir Behdad, Timothy J. Taxter, Vittorina Zagonel, Rebecca J. Nagy, Ricardo Lima Barros Costa, Kimberly S. Strickland, Laura K. Austin, Alfred W. Rademaker, Zhaomei Mu, Giovanna Rossi
Purpose: Liquid biopsy provides a real-time assessment of metastatic breast cancer (MBC). We evaluated the utility of combining circulating tumor cells (CTC) and circulating tumor DNA (ctDNA) to predict prognosis in MBC.Experimental Design: We conduc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aaf0a6e5431c1d655ece97b4cc45ef1
https://doi.org/10.1158/1078-0432.c.6525957.v1
https://doi.org/10.1158/1078-0432.c.6525957.v1
Autor:
Amrita, Basu, Gabriella K, Albert, Sabrina, Awshah, Jashodeep, Datta, Krithika N, Kodumudi, Corey, Gallen, Amber, Beyer, Keiran S M, Smalley, Paulo C, Rodriguez, Derek R, Duckett, Peter A, Forsyth, Aixa, Soyano, Gary K, Koski, Ricardo, Lima Barros Costa, Heather, Han, Hatem, Soliman, Marie Catherine, Lee, Pawel, Kalinski, Brian J, Czerniecki
Publikováno v:
Cancer immunology research. 10(1)
The HER3/ERBB3 receptor is an oncogenic receptor tyrosine kinase that forms heterodimers with EGFR family members and is overexpressed in numerous cancers. HER3 overexpression associates with reduced survival and acquired resistance to targeted thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0607fc7a71a38ee7f7f7b21c39d200dc
https://pubmed.ncbi.nlm.nih.gov/34785506
https://pubmed.ncbi.nlm.nih.gov/34785506
Publikováno v:
Clinical Rheumatology. 32:79-82
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by venous and/or arterial thrombosis or recurrent fetal loss associated with the presence of antiphospholipid antibodies and/or a lupus anticoagulant. The skin a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e1a36814760b9d1d370e307e63c6b1
https://doi.org/10.1007/s10067-010-1506-3
https://doi.org/10.1007/s10067-010-1506-3
Autor:
Ricardo Lima Barros Costa
Publikováno v:
American Journal of Hospice and Palliative Medicine®. 26:137-146
The National Hospice and Palliative Care Organization estimates that in 2006, 44.1% of hospice admissions had cancer as primary diagnosis, still representing the most common diagnosis in this level of care. In the recent years, the treatment of cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6229ff3be6dde94cf9d2577e34bfa7a1
https://doi.org/10.1177/1049909108330026
https://doi.org/10.1177/1049909108330026